X4 PHARMACEUTICALS, INC (XFOR) Gross margin 2024–2025
X4 PHARMACEUTICALS, INC (XFOR) gross margin by fiscal year — reported gross profit divided by reported revenue.
83.6%FY2025 · since FY2024: 68.8% → 83.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 83.6% | +14.8 pp |
| FY2024 | 68.8% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More XFOR financial trends
XFOR RevenueXFOR Net incomeXFOR Net marginXFOR Gross profitXFOR Operating incomeXFOR Operating marginXFOR Operating cash flowXFOR Free cash flowXFOR Capital expendituresXFOR Return on equityXFOR Stock buybacksXFOR Dividends paidXFOR Total assetsXFOR Total liabilitiesXFOR Shareholders’ equityXFOR overview →